aqueou
extract
sesquiterpen
lacton
xanthatin
xanthium
spinosum
l
favour
convers
xanthinin
xanthatin
via
loss
acet
acid
cytotox
human
cell
line
antivir
activ
isol
xanthatin
establish
natur
compound
show
signific
cytotox
cell
line
experiment
result
reveal
strong
antiangiogenesi
capac
vitro
structur
xanthatin
determin
spectroscop
method
first
time
confirm
xray
diffract
plant
xanthium
spinosum
l
asteracea
composita
object
larg
number
chemic
biolog
studi
use
tradit
medicin
differ
countri
extract
x
spinosum
l
contain
mixtur
compound
bsitosterol
quercetin
flavonoid
pendulin
iocein
centaurin
patuletin
moreov
contain
xanthanolid
sesquiterpen
lacton
xanthinin
xanthatin
stizolicin
solstitialin
fig
chloroform
extract
x
spinosum
aerial
part
report
use
treat
hydrophobia
treatment
rabi
intermitt
fever
well
treatment
diarrhoea
cancer
isol
sesquiterpen
lacton
xanthinin
stizolicin
solstitialin
test
antitumor
action
vitro
two
type
tumor
leukemia
leukemia
major
constitu
x
spinosum
dichloromethan
extract
show
antivir
properti
wherea
methanol
extract
xanthium
strumarium
leav
use
treat
inflammatori
diseas
rheumatoid
arthriti
also
show
anticanc
activ
ic
mgml
cell
respect
main
respons
constitu
inhibit
prolifer
human
tumor
cell
vitro
xanthanolid
epoxid
xanthanolid
class
sesquiterpenoid
isol
primarili
xanthium
famili
asteracea
chemic
structur
numer
xanthanolid
well
document
though
much
known
biolog
data
extract
synthet
prepar
gener
xanthanolid
present
gbutirolacton
fuse
sevenmemb
ring
depend
fusion
xanthanolid
divid
two
structur
type
ci
xanthanolid
number
transfus
lacton
fig
xanthatin
first
isol
xanthium
pennsylvanicum
j
e
littl
cowork
structur
establish
geissman
et
al
latter
group
suggest
possibl
xanthatin
could
form
xanthinin
dehydr
isol
particularli
purif
column
chromatographi
first
total
synthesi
xanthanolid
specif
dihydroxanthatin
report
morken
sequenti
rutheniumcatalys
metathesi
reaction
recent
shishido
cowork
report
enantiocontrol
total
synthesi
xanthatin
optic
pure
bicycl
lacton
sesquiterpen
lacton
exhibit
interest
biolog
activ
exploit
pharmaceut
industri
also
attract
consider
attent
organ
chemist
interest
synthet
rout
produc
natur
product
structur
character
use
extract
process
obtain
x
spinosum
evalu
anticanc
antivir
antiangiogen
activ
structur
establish
h
nmr
c
nmr
ir
ms
confirm
xray
crystallographi
first
time
result
crystal
structur
deposit
cambridg
crystallograph
data
centr
alloc
deposit
number
ccdc
melt
point
obtain
gallenkamp
apparatu
open
capillari
tube
uncorrect
ir
spectra
obtain
use
ftir
perkineelm
infrar
spectrophotomet
noteworthi
ir
absorpt
list
cm
h
c
nmr
spectra
record
varian
mhz
respect
varian
mhz
instrument
use
cdcl
solvent
tetramethylsilan
intern
standard
cd
co
h
nmr
spectra
heterocorrel
c
hmqc
hmbc
experi
record
varian
mhz
assign
establish
dept
hmbc
hmqc
mass
spectra
record
thermofinnigan
trace
dsq
equip
apci
esi
sourc
highresolut
esim
measur
lcmsdtof
mass
spectromet
intern
refer
mass
mz
purin
data
acquisit
process
perform
xcalibur
softwar
column
chromatographi
perform
silica
gel
e
merck
mesh
reaction
monitor
tlc
use
mm
silica
gel
f
plate
e
merck
detect
achiev
absorb
uv
light
nm
nm
spray
differ
reagent
sulfur
ww
ceric
sulfat
follow
heat
min
c
depend
use
reagent
r
f
valu
obtain
analyt
tlc
microanalysi
determin
carlo
analys
reagent
commerci
qualiti
purifi
use
organ
solvent
analyt
grade
purifi
standard
procedur
commerci
solvent
purchas
sigmaealdrich
product
extract
previous
dissolv
mgml
dmso
treatment
solut
dilut
dmem
contain
fc
penicillinstreptomycin
aerial
fresh
young
plant
x
spinosum
asteracea
famili
collect
june
juli
barcelona
coastlin
spain
authent
comparison
sampl
speci
deposit
institut
botan
csicajunta
de
barcelona
spain
speci
airdri
ground
dri
residu
g
x
spinosum
l
soak
ml
water
mixtur
heat
c
ultrasound
bath
min
residu
filter
suction
filtrat
extract
ethyl
ether
ethyl
acet
portion
solid
residu
discard
combin
organ
extract
dri
na
filter
solvent
remov
vacuum
residu
obtain
evapor
solvent
satisfactorili
purifi
column
chromatographi
use
column
cm
high
place
diamet
cm
pack
slurri
silica
gel
hexan
residu
dissolv
minimum
amount
necessari
dichloromethan
appli
pipett
top
silica
bed
column
elut
hexaneethyl
acet
mixtur
increas
polar
solvent
system
solvent
gradient
use
rang
hexan
ethyl
acet
fraction
ml
collect
fraction
collect
manual
similar
tlc
profil
pool
xanthatin
elut
hexaneethyl
acet
caffeic
acid
obtain
elut
ethyl
acet
xanthatin
extract
x
spinosum
white
solid
solubl
chloroform
dichloromethan
methanol
aceton
slightli
solubl
cold
water
xanthatin
obtain
purifi
column
chromatographi
use
silica
gel
puriti
analyt
biolog
test
xanthatin
ca
iupac
name
e
e
b
structur
establish
spectral
method
confirm
xray
diffract
analyt
data
also
compar
bibliograph
report
data
white
needl
methanol
mp
c
c
studi
perform
human
hepat
cellular
carcinoma
cell
ecacc
n
cell
cultur
dmem
supplement
mm
glutamin
heatinactiv
fc
fetal
calf
serum
unitsml
penicillin
mgml
streptomycin
cell
maintain
c
vitro
monolay
cultur
place
cm
diamet
cultur
wellplat
humidifi
atmospher
co
confluenc
cell
subcultur
follow
trypsin
centrifug
everi
day
depend
number
cell
cell
viabil
differ
experi
cell
count
assess
trypan
blue
exclus
dye
use
haemocytomet
drug
test
ad
cultur
one
day
seed
cell
ensur
uniform
attach
cell
begin
experi
determin
antiprolif
activ
tell
cell
line
viabil
cultur
cell
determin
assay
reduct
mtt
cell
metabol
capac
reduc
mtt
formazan
assay
perform
variat
method
describ
mosmann
cellswel
seed
well
plate
ml
medium
h
incub
c
ensur
cell
adher
medium
remov
new
medium
ad
contain
differ
concentr
compound
cell
incub
h
c
humidifi
incub
co
incub
mtt
ad
final
concentr
mgml
medium
cell
incub
h
c
ml
dmso
ad
per
well
dissolv
formazan
crystal
rel
cell
viabil
obtain
measur
absorb
elisa
plate
reader
tecan
sunris
tecan
austria
nm
absorb
directli
proport
level
cell
prolifer
viabil
ic
valu
determin
doseerespons
curv
use
differ
concentr
concentr
analys
triplic
antivir
activ
xanthatin
evalu
follow
virus
herp
simplex
viru
type
herp
simplex
viru
type
varicelazost
viru
vzv
vesicular
stomat
viru
vaccinia
viru
felin
corona
viru
fipv
felin
herp
viru
coxsacki
viru
respiratori
syncyti
viru
influenza
h
n
influenza
h
n
influenza
b
viru
sindbi
viru
punta
toro
viru
antiviru
assay
method
describ
previous
antivir
activ
evalu
base
inhibit
viru
induc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
cell
vero
human
epitheli
cell
hela
crandellre
felin
kidney
cell
crfk
human
embryon
lung
hel
fibroblast
grown
microtitr
plate
infect
correspond
viru
incub
h
incub
period
residu
viru
remov
infect
cell
incub
medium
contain
differ
concentr
xanthatin
duplic
day
cell
cultur
examin
microscop
antivir
activ
express
effect
concentr
requir
reduc
viral
plaqu
format
day
compar
untreat
control
freshli
cut
aortic
ring
obtain
fischer
male
rat
embed
collagen
gel
transfer
mm
well
contain
ml
mcdb
describ
control
treat
vehicl
alon
dimethylsulfoxid
dmso
microvascular
growth
curv
characterist
gel
experi
includ
minimum
three
four
observ
per
data
point
repeat
least
two
time
statist
calcul
carri
microsoft
offic
excel
result
express
mean
sem
minimum
independ
experi
student
ttest
use
statist
analys
p
valu
consid
signific
xanthatin
previous
extract
sever
genera
xanthium
genera
asteracea
famili
use
organ
solvent
aceton
dichloromethan
methanol
other
aqueou
reflux
therefor
geissman
cowork
convert
xanthinin
xanthatin
treatment
sodium
acet
ethanol
work
determin
princip
constitu
infus
x
spinosum
extract
perform
boil
dri
extract
water
short
period
time
assist
ultrasound
crude
residu
repres
dri
weight
fresh
plant
x
spinosum
use
start
materi
simpl
process
requir
littl
time
min
mild
temperatur
c
soft
frequenc
rang
khz
effici
condit
favour
convers
xanthinin
xanthatin
would
explain
format
xanthatin
detect
xanthinin
deriv
caffeic
acid
obtain
dri
plant
weight
sampl
g
plant
powder
g
xanthatin
obtain
repres
dri
plant
weight
fresh
plant
weight
quantiti
higher
publish
work
infus
g
dri
plant
contain
approxim
mg
xanthatin
mg
caffeic
acid
extract
procedur
sesquiterpen
isol
structur
studi
h
nmr
c
nmr
cheteronuclear
shift
correl
spectra
use
rel
stereochemistri
xanthatin
determin
first
time
xray
diffract
thu
wherea
presenc
gbutirolacton
condens
cyclohepten
ring
posit
side
chain
aexocycl
methylen
group
posit
confirm
singlecryst
xray
crystallograph
analysi
fig
analyt
data
verifi
comparison
report
literatur
structur
evid
main
compound
isol
identifi
xanthatin
cytotox
xanthatin
hepatocellular
carcinoma
human
mous
lymphocyt
leukemia
cell
cultur
evalu
antivir
properti
capac
inhibit
angiogenesi
also
test
cytotox
properti
xanthium
asteracea
well
known
vitro
cytotox
isol
xanthatin
less
studi
inhibit
cell
prolifer
observ
follow
treatment
cell
line
xanthatin
concentr
requir
inhibit
growth
ic
h
cell
mm
fig
mm
cell
rel
percentag
cell
prolifer
calcul
consid
untreat
control
cell
h
cell
prolifer
xanthatin
show
inhibitori
activ
wide
varieti
viru
includ
herp
simplex
vaccinia
vesicular
stomat
hel
cell
cultur
felin
corona
felin
herp
crfk
cell
cultur
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
hela
cell
cultur
result
compar
obtain
refer
compound
brivudin
ribavirin
ciclofovir
ganciclovir
xanthatin
lack
inhibitori
activ
three
type
influenza
test
influenza
h
n
influenza
h
n
influenza
b
tabl
xanthatin
show
pronounc
cytotox
activ
mdck
cell
cultur
influenza
also
vero
cell
cultur
minim
cytotox
concentr
mcc
mm
respect
tabl
natur
compound
possess
rel
high
toxic
therapeut
index
cc
ec
sever
viru
test
mcc
valu
rang
ec
valu
format
neovessel
endothelium
preexist
vessel
essenti
part
embryon
develop
tissu
repair
play
critic
role
progress
sever
fatal
diseas
includ
cancer
diabet
rheumatoid
arthriti
vasculatur
densiti
correl
malign
aggress
tumor
angiogenesi
favour
growth
solid
tumor
well
invas
metastasi
clinic
result
first
gener
antiangiogen
drug
demonstr
addit
clinic
benefit
compar
classic
antitumor
treatment
consequ
research
need
obtain
promis
angiogenesi
inhibitor
rat
aortic
ring
explant
model
threedimension
collagen
gel
matrix
huvec
capillari
tube
format
assay
matrigel
synthet
basement
membran
matrix
commonli
use
vitro
angiogenesi
system
antiangiogen
respons
xanthatin
evalu
vitro
rat
aorta
ring
explant
cultur
presenc
exogen
vegf
stimul
doserel
inhibitori
effect
microvessel
growth
observ
mm
mm
fig
nm
mm
xanthatin
fig
xanthatin
display
signific
inhibit
ic
mm
capillari
tube
format
measur
area
mm
regard
concentr
xanthatin
test
rel
untreat
control
antiangiogen
respons
compar
effect
paclitaxel
ic
mm
consid
one
best
antiangiogen
drug
xanthatin
paclitaxel
show
similar
behaviour
thu
antiangiogen
effect
xanthatin
paclitaxel
prevail
low
dose
high
dose
show
cytotox
activ
moreov
inhibit
angiogenesi
dosedepend
either
compound
inhibit
angiogenesi
previous
studi
either
xanthatin
xanthium
extract
properti
could
use
treatment
solid
tumor
conclus
although
xanthatin
isol
sever
speci
asteracea
famili
first
report
fast
aqueou
extract
x
spinosum
also
first
xray
confirm
structur
propos
geissman
co
worker
procedur
allow
xanthinin
transform
xanthatin
perform
puriti
compound
increas
xanthatin
show
cytotox
cell
line
excel
inhibit
angiogenesi
observ
compar
paclitaxel
also
xanthatin
show
inhibitori
activ
sever
virus
therapeut
index
xanthatin
isol
x
spinosum
small
quantiti
total
synthesi
often
difficult
isol
compound
could
use
lead
compound
develop
xanthatin
deriv
therapeut
effect
present
studi
suggest
xanthatin
play
import
role
angiogenesi
inhibit
promis
tumor
treatment
research
requir
elucid
mechan
action
class
compound
